By Pushkala Aripaka and Yadarisa Shabong (Reuters) -British healthcare property developer Assura has rejected a 1.56 billion pound ($2 billion) acquisition bid from KKR and pension fund Universities Superannuation Scheme, the U.S.-based private equity group said on Monday. Assura's shares jumped nearly 18% to 46 pence, still just over half of their peak price of 88 pence in 2020. KKR said it had made four indicative, non-binding proposals to Assura, the latest of which was at 48 pence per share, a 28.2% premium to Assura's closing price on February 13, but was rejected by the British company's board. "KKR is considering whether there is any merit in continuing to try and engage with the board," the U.S. group said in a statement. USS, which had established a joint venture with Assura last year, said in a separate statement that it did not intend to make an offer for Assura, as part of the consortium or otherwise. It was not clear whether KKR was considering an independent offer. It declined to comment further. Some of the past bids for Assura were made by KKR on its own and any future attempt would likely be an independent one as USS backed out, a source familiar with the situation told Reuters. Assura declined to comment on the developments. The company undertook asset disposals last year to bolster its balance sheet. It was running more than 600 properties with an investment value of about 3.2 billion pounds as of September, and counts Britain's state-backed National Health Service as a customer. "(Assura) is well-managed, has a high quality portfolio and many attributes of obvious attraction to the bidder," Shore Capital analyst Andrew Saunders said in a note. Deal-making activity in Britain picked up last year, as cheaper valuations and falling or stable interest rates made financing easier for buyouts. A Deutsche Numis poll showed that private equity firms expect a rise in deal activity in 2025. Under British takeover rules, KKR and USS have until March 14 to make a firm offer for Assura or walk away. ($1 = 0.7940 pounds) (Reporting by Pushkala Aripaka and Yadarisa Shabong in Bengaluru; Editing by Rashmi Aich and Emelia Sithole-Matarise)
UK's Assura rejects $2 billion buyout bid from KKR, pension fund
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...